Product Information
CARBAMAZEPINE 200 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1190 per EA under NDC 29300038201. Its NADAC has been published 131 times since Nov 22, 2023.
FDA first approved this application on Aug 22, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300038201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA213284FDA Approved
8/22/2022
TE Code
AB
On Market Since
11/1/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE 200 MG TABLET has been published 131 times since Nov 22, 2023, and over the history we have for it it has declined 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1190 per EA |
|---|---|
| All-time high | $0.1977 (Dec 11, 2024) |
| All-time low | $0.1005 (Aug 21, 2024) |
| 52-week high | $0.1261 |
| 52-week low | $0.1157 |
| Median price | $0.1261 |
| Average price | $0.1351 |
| Largest weekly change | +96.7% (Aug 28, 2024) |
| Weeks tracked | 131 |
| Tracking since | Nov 22, 2023 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 200 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1190 per EA (NDC 29300038201), effective Aug 19, 2026.
How has the price of CARBAMAZEPINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE 200 MG TABLET has declined 20.0%. It has been tracked across 131 weekly CMS publications since Nov 22, 2023.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 200 MG TABLET?
Since Nov 22, 2023, the NADAC for CARBAMAZEPINE 200 MG TABLET has ranged from a low of $0.1005 (Aug 21, 2024) to a high of $0.1977 (Dec 11, 2024), with a median of $0.1261 per EA.
Are there cheaper alternatives to CARBAMAZEPINE 200 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPITOL 200 MG TABLET, is $0.1170 per EA — about 2% below CARBAMAZEPINE 200 MG TABLET.
Who manufactures CARBAMAZEPINE 200 MG TABLET?
CARBAMAZEPINE 200 MG TABLET (NDC 29300038201) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.